Guillain-Barré is a condition in which the immune system attacks the nervous system, resulting in rapid-onset muscle weakness and sometimes paralysis. Of 42 patients who tested positive for Zika-fighting antibodies, 41 were diagnosed with Guillain-Barré, according to the researchers. The risk for Zika-positive patients developing the syndrome increased as much as 24-fold.
“This is the first study providing evidence for Zika virus infection causing Guillain-Barré syndrome,” the authors conclude. “Because Zika virus is spreading rapidly across the Americas, at risk countries need to prepare for adequate intensive care beds capacity to manage patients with Guillain-Barré syndrome.”
More articles on infection control:
CDC investigates 14 new sexually transmitted Zika cases in US
Chicago’s first Zika virus case confirmed
Zika pregnances still producing mixed outcomes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
